Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Multiple myeloma (MM) accounts for 1% of all cancers and ∼ 10% of all haematological malignancies. The incidence in Europe is 4.5-6.0/100 000/year with a median
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 July 2017
|
| In: |
Annals of oncology
Year: 2017, Volume: 28, Pages: iv52-iv61 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx096 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx096 Verlag, Volltext: https://academic.oup.com/annonc/article/28/suppl_4/iv52/3768071 
|
| Author Notes: | P. Moreau, J. San Miguel, P. Sonneveld, M.V. Mateos, E. Zamagni, H. Avet-Loiseau, R. Hajek, M.A. Dimopoulos, H. Ludwig, H. Einsele, S. Zweegman, T. Facon, M. Cavo, E. Terpos, H. Goldschmidt, M. Attal, C. Buske |
| Summary: | Multiple myeloma (MM) accounts for 1% of all cancers and ∼ 10% of all haematological malignancies. The incidence in Europe is 4.5-6.0/100 000/year with a median |
|---|---|
| Item Description: | Gesehen am 08.05.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx096 |